Exact Mass: 570.2267

Exact Mass Matches: 570.2267

Found 26 metabolites which its exact mass value is equals to given mass value 570.2267, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Midostaurin

Midostaurin

C35H30N4O4 (570.2267)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor D000970 - Antineoplastic Agents

   

Benzoylstaurosporine

N-((9S,10R,11R,13R)-10-Methoxy-9-methyl-1-oxo-2,3,10,11,12,13-hexahydro-9,13-epoxy-1H,9H-diindolo(1,2,3-gh:3,2,1-LM)pyrrolo(3,4-J)(1,7)benzodiazonin-11-yl)-N-methylbenzamide

C35H30N4O4 (570.2267)


D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents

   

N-Benzoylstaurosporine

N-Benzoylstaurosporine

C35H30N4O4 (570.2267)


   

PKC 412

N-[(9S,10R,11R,13R)-2,3,10,11,12,13-hexahydro-10-methoxy-9-methyl-1-oxo-9,13-epoxy-1H,9H-diindolo[1,2,3-gh:3,2,1-lm]pyrrolo[3,4-j][1,7]benzodiazonin-11-yl]-N-methyl-benzamide

C35H30N4O4 (570.2267)


D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents

   

(s)-1-[(r)-2-(di-tert.-butylphosphino)ferrocenyl]ethylbis(2-methylphenyl)phosphi

(s)-1-[(r)-2-(di-tert.-butylphosphino)ferrocenyl]ethylbis(2-methylphenyl)phosphi

C34H44FeP2 (570.2267)


   

(GalNAc)1 (GlcNAc)1 (LFuc)1

(GalNAc)1 (GlcNAc)1 (LFuc)1

C22H38N2O15 (570.2272)


   

N-acetyl-beta-D-glucosaminyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosamine

N-acetyl-beta-D-glucosaminyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosamine

C22H38N2O15 (570.2272)


   

beta-D-GlcpNAc-(1->4)-[alpha-L-Fucp-(1->6)]-beta-D-GlcpNAc

beta-D-GlcpNAc-(1->4)-[alpha-L-Fucp-(1->6)]-beta-D-GlcpNAc

C22H38N2O15 (570.2272)


   

GlcNAc(a1-4)[Fuc(b1-6)]a-GlcNAc

GlcNAc(a1-4)[Fuc(b1-6)]a-GlcNAc

C22H38N2O15 (570.2272)


   

GlcNAc(b1-4)[Fuc(b1-6)]b-GlcNAc

GlcNAc(b1-4)[Fuc(b1-6)]b-GlcNAc

C22H38N2O15 (570.2272)


   

alpha-L-fucosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-N-acetyl-D-glucosamine

alpha-L-fucosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-N-acetyl-D-glucosamine

C22H38N2O15 (570.2272)


   

2-acetamido-2-deoxy-beta-D-galactopyranosyl-(1->4)-[alpha-L-fucopyranosyl-(1->3)]-2-acetamido-2-deoxy-beta-D-glucopyranose

2-acetamido-2-deoxy-beta-D-galactopyranosyl-(1->4)-[alpha-L-fucopyranosyl-(1->3)]-2-acetamido-2-deoxy-beta-D-glucopyranose

C22H38N2O15 (570.2272)


   

Fuc(a1-6)[GlcNAc(b1-4)]GlcNAc

Fuc(a1-6)[GlcNAc(b1-4)]GlcNAc

C22H38N2O15 (570.2272)


   

GlcNAc(b1-4)[Fuc(a1-6)]a-GlcNAc

GlcNAc(b1-4)[Fuc(a1-6)]a-GlcNAc

C22H38N2O15 (570.2272)


   

GlcNAc(a1-4)[Fuc(b1-6)]b-GlcNAc

GlcNAc(a1-4)[Fuc(b1-6)]b-GlcNAc

C22H38N2O15 (570.2272)


   

Fuc(a1-3)GlcNAc(b1-6)a-GalNAc

Fuc(a1-3)GlcNAc(b1-6)a-GalNAc

C22H38N2O15 (570.2272)


   

Fuc(a1-3)GlcNAc(b1-6)GalNAc

Fuc(a1-3)GlcNAc(b1-6)GalNAc

C22H38N2O15 (570.2272)


   

Fuc(b1-3)[GlcNAc(b1-4)]b-GlcNAc

Fuc(b1-3)[GlcNAc(b1-4)]b-GlcNAc

C22H38N2O15 (570.2272)


   

GlcNAc(b1-4)[Fuc(b1-6)]a-GlcNAc

GlcNAc(b1-4)[Fuc(b1-6)]a-GlcNAc

C22H38N2O15 (570.2272)


   

Fuc(b1-3)[GlcNAc(a1-4)]a-GlcNAc

Fuc(b1-3)[GlcNAc(a1-4)]a-GlcNAc

C22H38N2O15 (570.2272)


   

Fuc(b1-3)[GlcNAc(a1-4)]b-GlcNAc

Fuc(b1-3)[GlcNAc(a1-4)]b-GlcNAc

C22H38N2O15 (570.2272)


   

GlcNAc(a1-4)[Fuc(a1-6)]b-GlcNAc

GlcNAc(a1-4)[Fuc(a1-6)]b-GlcNAc

C22H38N2O15 (570.2272)


   

Fuc(a1-3)[GlcNAc(a1-4)]b-GlcNAc

Fuc(a1-3)[GlcNAc(a1-4)]b-GlcNAc

C22H38N2O15 (570.2272)


   

Fuc(a1-3)[GlcNAc(b1-4)]a-GlcNAc

Fuc(a1-3)[GlcNAc(b1-4)]a-GlcNAc

C22H38N2O15 (570.2272)


   

Fuc(a1-3)[GlcNAc(b1-4)]GlcNAc

Fuc(a1-3)[GlcNAc(b1-4)]GlcNAc

C22H38N2O15 (570.2272)


   

GlcNAc(b1-3)[Fuc(b1-6)]b-GlcNAc

GlcNAc(b1-3)[Fuc(b1-6)]b-GlcNAc

C22H38N2O15 (570.2272)